PlainRecalls
FDA Drug Critical Class I Terminated

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Reported: May 20, 2020 Initiated: April 14, 2020 #D-1269-2020

Product Description

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Reason for Recall

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Details

Recalling Firm
MasterPharm LLC
Units Affected
7260 capsules
Distribution
Nationwide in the U.S.
Location
South Richmond Hill, NY

Frequently Asked Questions

What product was recalled?
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.. Recalled by MasterPharm LLC. Units affected: 7260 capsules.
Why was this product recalled?
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 20, 2020. Severity: Critical. Recall number: D-1269-2020.